Leishmanicidal metabolites from Cochliobolus sp., an endophytic fungus isolated from Piptadenia adiantoides (Fabaceae)

PLoS Neglected Tropical Diseases

Volumn 2, Issue 12, 2008, Pages

  Campos, Fernanda Fraga ^a,b   Rosa, Luiz Henrique ^c   Cota, Betania Barros ^a   Caligiorne, Rachel Basques ^a   Teles Rabello, Ana Lúcia ^a   Alves, Tânia Maria Almeida ^a   Rosa, Carlos Augusto ^b   Zani, Carlos Leomar ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; COCHLIOQUINONE A; ISOCOCHLIOQUINONE A; NATURAL PRODUCT; RIBOSOME DNA; UNCLASSIFIED DRUG; BENZOQUINONE DERIVATIVE; CHOLESTEROL ACYLTRANSFERASE; FUNGAL DNA; OXIDOREDUCTASE; PRIMER DNA; RECOMBINANT PROTEIN; TRYPANOTHIONE REDUCTASE;

AMASTIGOTE; ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CHROMATOGRAPHY; COCHLIOBOLUS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG SELECTIVITY; DRUG STRUCTURE; FUNGUS ISOLATION; HUMAN; HUMAN CELL; LEISHMANIA; LEISHMANIASIS; METABOLITE; NONHUMAN; NUCLEOTIDE SEQUENCE; PIPTADENIA ADIANTOIDES; PLANT; AFRICA SOUTH OF THE SAHARA; ANIMAL; ASCOMYCETES; BREAST TUMOR; CENTRAL AMERICA; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; GENETICS; ISOLATION AND PURIFICATION; KIDNEY TUMOR; LEGUME; LEISHMANIA MEXICANA; MELANOMA; METABOLISM; MICROBIOLOGY; PARASITOLOGY; SOUTH AMERICA; TROPIC CLIMATE; TRYPANOSOMA; TRYPANOSOMA CRUZI; TUMOR CELL LINE; WORLD HEALTH ORGANIZATION;

AFRICA SOUTH OF THE SAHARA; ANIMALS; ASCOMYCOTA; BENZOQUINONES; BREAST NEOPLASMS; CELL LINE, TUMOR; CENTRAL AMERICA; DNA PRIMERS; DNA, FUNGAL; DNA, RIBOSOMAL; FABACEAE; FEMALE; HUMANS; KIDNEY NEOPLASMS; LEISHMANIA MEXICANA; MELANOMA; NADH, NADPH OXIDOREDUCTASES; RECOMBINANT PROTEINS; SOUTH AMERICA; STEROL O-ACYLTRANSFERASE; TROPICAL CLIMATE; TRYPANOSOMA; TRYPANOSOMA CRUZI; WORLD HEALTH ORGANIZATION;

EID: 65549154080     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000348     Document Type: Article

References (42)

1. WHO (2008) World Health Organization. Control of Neglected Tropical Diseases (NTD): Neglected tropical diseases frequently asked questions. http://www.who.int/neglected_diseases/faq/en/index.html. Accessed: 11 November 2008.
2. DNDi (2008) Drugs for Neglected Diseases Initiative. http://www.dndi.org/ cms/public_html/insidecategoryListing.asp?CategoryId=89. Accessed: 11 November 2008.
3. Torreele E (2006) No drugs in an age of plenty: urging governments to redress the balance. Interdisciplinary Science Reviews 31: 3-8.
4. Tan RX, Zou WX (2001) Endophytes: a rich source of functional metabolites. Natural Product Reports 18: 448-459.
5. Schulz B, Boyle C, Draeger S, Rommert AK, Krohn K (2002) Endophytic fungi: a source of novel biologically active secondary metabolites. Mycological Research 106: 996-1004.
6. Strobel G, Daisy B, Castillo U, Harper J (2004) Natural products from endophytic microorganisms. Journal of Natural Products 67: 257-268.
7. Gunatilaka AAL (2006) Natural products from plant-associated microorganisms: Distribution, structural diversity, bioactivity, and implications of their occurrence. Journal of Natural Products 69: 509-526.
8. Kettering M, Sterner O, Anke T (2004) Antibiotics in the chemical communication of fungi. Zeitschrift Fur Naturforschung C-a Journal of Biosciences 59: 816-823.
9. Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A (1985) Trypanothione - a novel bis(glutathionyl)spermidine cofactor for glutathione-reductase in trypanosomatids. Science 227: 1485-1487.
10. Fairlamb AH, Cerami A (1992) Metabolism and functions of trypanothione in the kinetoplastida. Annual Review of Microbiology 46: 695-729.
11. Henderson GB, Fairlamb AH (1987) Trypanothione metabolism-a chemotherapeutic target in trypanosomatids. Parasitology Today 3: 312-315.
12. Frearson JA, Wyatt PG, Gilbert IH, Fairlamb AH (2007) Target assessment for antiparasitic drug discovery. Trends in Parasitology 23: 589-595.
13. de Hoog GS, Vicente V, Caligiorne RB, Kantarcioglu S, Tintelnot K, et al. (2003) Species diversity and polymorphism in the Exophiala spinifera clade containing opportunistic black yeast-like fungi. Journal of Clinical Microbiology 41: 4767-4778.
14. White TJ, Bruns TD, Lee SB (1989) Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis NA, GJ, Sninsky J, et al., eds. PCR protocols: A guide to methods and applications. San Diego, CA: Academic Press. pp 315-322.
15. Green P (2008) http://www.phrap.org. Accessed: 11 November 2008.
16. Altschul SF, Madden TL, Schaffer AA, Zhang JH, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 25: 3389-3402.
17. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Molecular Biology and Evolution 24: 1596-1599.
18. Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide-sequences. Journal of Molecular Evolution 16: 111-120.
19. Hamilton CJ, Saravanamuthu A, Eggleston IM, Fairlamb AH (2003) Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate economical microplate and time-dependent inhibition assays for trypanothione reductase. Biochemical Journal 369: 529-537.
20. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, et al. (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor-cell lines. Journal of the National Cancer Institute 83: 757-766.
21. Shoemaker RH (2006) The NCI60 human tumour cell line anticancer drug screen. Nature Reviews Cancer 6: 813-823.
22. Teixeira MCA, Santos RD, Sampaio RB, Pontes-de-Carvalho L, dos-Santos WLC (2002) A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species. Parasitology Research 88: 963-968.
23. Yarrow D (1998) Methods for the isolation, maintenance and identification of yeast. In: Fell JW, ed. The yeast: a taxonomic study. Amsterdam: Elsevier. pp 77-105.
24. Index Fungorum (2008) Available: http://indexfungorum.org/Names/ Names.asp. Accessed: 11 November 2008.
25. Aggarwal R, Tewari AK, Srivastava KD, Singh DV (2004) Role of antibiosis in the biological control of spot blotch (Cochliobolus sativus) of wheat by Chaetomium globosum. Mycopathologia 157: 369-377.
26. Jacobson M, Galetta SL, Atlas SW, Curtis MT, Wulc AW (1992) Bipolaris-induced orbital cellulitis. Journal of Clinical Neuro-Ophthalmology 12: 250-256.
27. Maskin SL, Fetchick RJ, Leone CR, Sharkey PK, Rinaldi MG (1989) Bipolaris hawaiiensis-caused pheohyphomycotic orbitopathy - a devastating fungal sinusitis in an apparently immunocompetent host. Ophthalmology 96: 175-179.
28. Miyagawa H, Nagai S, Tsurushima T, Sato M, Ueno T, et al. (1994) Phytotoxins produced by the plant-pathogenic fungus Bipolaris bicolor el-1. Bioscience Biotechnology and Biochemistry 58: 1143-1145.
29. Jung HJ, Lee HB, Lim CH, Kim CJ, Kwon HJ (2003) Cochlioquinone A1, a new anti-angiogenic agent from Bipolaris zeicola. Bioorganic & Medicinal Chemistry 11: 4743-4747.
30. Yoganathan K, Yang LK, Rossant C, Huang YC, Ng S, et al. (2004) Cochlioquinones and epi-cochlioquinones: Antagonists of the human chemokine receptor CCR5 from Bipolaris brizae and Stachybotrys chartarum. Journal of Antibiotics 57: 59-63.
31. Lim CH, Miyagawa H, Tsurushima T, Ueno T, Sato M (1996) Cochlioquinol: A new cochlioquinone derivative produced by the plant pathogenic fungus Bipolaris cynodontis. Bioscience Biotechnology and Biochemistry 60: 724-725.
32. Ashley JN, Raistrick H (1938) Studies in the biochemistry of micro-organisms LVI. Luteoleersin and alboleersin; Metabolic products of Helminthosporium leersii Atkinson. A possible oxidation-reduction system. Biochemical Journal 32: 449-454.
33. Machida T, Higashi K, Ogawara H (1995) Cochlioquinone-a, an inhibitor of diacylglycerol kinase. Journal of Antibiotics 48: 1076-1080.
34. Wang XH, Thomas B, Sachdeva R, Arterburn L, Frye L, et al. (2006) Mechanism of arylating quinone toxicity involving Michael adduct formation and induction of endoplasmic reticulum stress. Proceedings of the National Academy of Sciences of the United States of America 103: 3604-3609.
35. Martyn DC, Jones DC, Fairlamb AH, Clardy J (2007) High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity. Bioorganic & Medicinal Chemistry Letters 17: 1280-1283.
36. Schaeffer JM, Frazier EG, Bergstrom AR, Williamson JM, Liesch JM, et al. (1990) Cochlioquinone-a, a nematocidal agent which competes for specific [h-3] ivermectin binding-sites. Journal of Antibiotics 43: 1179-1182.
37. Rasheid K, Morsy T (1998) Efficacy of ivermectin on the infectivity of Leishmania major promastigotes. J Egypt Soc Parasitol 28: 207-212.
38. Rifaat LK, Mohammad MA, Jawdat SZ (1989) Ivermectin, levamisole and thymic extract for chemotherapy and immunostimulation of visceral leishmaniasis in hamsters and mice. Japanese Journal of Medical Science & Biology 42: 51-61.
39. Cheeseman CL, Delany NS, Woods DJ, Wolstenholme AJ (2001) High-affinity ivermectin binding to recombinant subunits of the Haemonchus contortus glutamate-gated chloride channel. Molecular and Biochemical Parasitology 114: 161-168.
40. Osterhage C, Konig GM, Holler U, Wright AD (2002) Rare sesquiterpenes from the algicolous fungus Drechslera dematioidea. Journal of Natural Products 65: 306-313.
41. Phuwapraisirisan P, Sawang K, Siripong P, Tip-Pyang S (2007) Anhydrocochlioquinone A, a new antitumor compound from Bipolaris oryzae. Tetrahedron Letters 48: 5193-5195.
42. Canonica L, Beretta MG, Colombo L, Gennari C, Ranzi BM, et al. (1980) Biosynthesis of cochlioquinones. Journal of the Chemical Society-Perkin Transactions 1: 2686-2690.